Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:12:39.463Z.
Calculation as of: 2026-10-06T16:12:39.463Z.
Quote observation: 2026-10-06T16:08:36.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 49c5230cca2432c6fd0637270100fe2f3d02ebc9238e4fdbb1f4ddcca099658b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2021-08-10.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
OPERATING CASH FLOW YIELD AVG TTM
N/A
OPERATING CASH FLOW YIELD AVG 3Y
N/A
OPERATING CASH FLOW YIELD AVG 5Y
N/A
OPERATING CASH FLOW YIELD AVG 10Y
N/A
OPERATING CASH FLOW YIELD AVG 15Y
N/A
OPERATING CASH FLOW YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
iSpecimen Inc.
Market Cap
$2.63M
Operating Cash Flow Yield
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD |
|---|---|---|
| iSpecimen Inc. (ISPC) | $2.63M | N/A |
| Nuwellis, Inc. (NUWE)vs › | $2.59M | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.57M | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.53M | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.52M | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.41M | N/A |
| Onconetix, Inc. (ONCO)vs › | $2.38M | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.35M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.00M | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.25M | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING CASH FLOW YIELD |
|---|---|
| 2021-08-10 | 0.03% |
| 2021-08-09 | 0.03% |
| 2021-08-06 | 0.03% |
| 2021-08-05 | 0.03% |
| 2021-08-04 | 0.03% |
| 2021-08-03 | 0.03% |
| 2021-08-02 | 0.03% |
| 2021-07-30 | 0.03% |
| 2021-07-29 | 0.03% |
| 2021-07-28 | 0.03% |
| 2021-07-27 | 0.03% |
| 2021-07-26 | 0.03% |
| 2021-07-23 | 0.03% |
| 2021-07-22 | 0.03% |
| 2021-07-21 | 0.03% |
| 2021-07-20 | 0.03% |
| 2021-07-19 | 0.03% |
| 2021-07-16 | 0.03% |
| 2021-07-15 | 0.03% |
| 2021-07-14 | 0.03% |
| 2021-07-13 | 0.03% |
| 2021-07-12 | 0.03% |
| 2021-07-09 | 0.03% |
| 2021-07-08 | 0.03% |
| 2021-07-07 | 0.02% |
| 2021-07-06 | 0.03% |
| 2021-07-02 | 0.03% |
| 2021-07-01 | 0.02% |
| 2021-06-30 | 0.02% |
| 2021-06-29 | 0.02% |
| 2021-06-28 | 0.02% |
| 2021-06-25 | 0.03% |
| 2021-06-24 | 0.03% |
| 2021-06-23 | 0.03% |
| 2021-06-22 | 0.02% |
| 2021-06-21 | 0.02% |
| 2021-06-18 | 0.02% |
| 2021-06-17 | 0.02% |
